183 related articles for article (PubMed ID: 17886207)
1. [Therapy with vasopressin receptor antagonists: the aquaretics].
Buemi M; Bolignano D; Coppolino G; Sturiale A; Campo S; Crasci' E; Aloisi C; Frisina N
G Ital Nefrol; 2007; 24(5):371-80. PubMed ID: 17886207
[TBL] [Abstract][Full Text] [Related]
2. Aquaretic agents: what's beyond the treatment of hyponatremia?
Bolignano D; Coppolino G; Criseo M; Campo S; Romeo A; Buemi M
Curr Pharm Des; 2007; 13(8):865-71. PubMed ID: 17430186
[TBL] [Abstract][Full Text] [Related]
3. The role of V2 vasopressin antagonists in hyponatremia.
Palm C; Reimann D; Gross P
Cardiovasc Res; 2001 Aug; 51(3):403-8. PubMed ID: 11476730
[TBL] [Abstract][Full Text] [Related]
4. Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions.
Urso C; Brucculeri S; Caimi G
J Clin Pharm Ther; 2015 Aug; 40(4):376-85. PubMed ID: 25924179
[TBL] [Abstract][Full Text] [Related]
5. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
Decaux G
J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents.
Leiva JG; Salgado JM; Estradas J; Torre A; Uribe M
Ann Hepatol; 2007; 6(4):214-21. PubMed ID: 18007550
[TBL] [Abstract][Full Text] [Related]
7. [The use of tolvaptan in a case of severe hyponatriemia in SIADH during meningitis].
Rollino C; Balbiano R; Caramello P; Roccatello D
G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402662
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of vasopressin receptor antagonists.
Ishikawa S; Saito T
Intern Med; 1998 Feb; 37(2):217-9. PubMed ID: 9550616
[No Abstract] [Full Text] [Related]
9. Vasopressin V2-receptor antagonists: panaceas for hyponatremia?
Kitiyakara C; Wilcox CS
Curr Opin Nephrol Hypertens; 1997 Sep; 6(5):461-7. PubMed ID: 9327205
[TBL] [Abstract][Full Text] [Related]
10. Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Gassanov N; Semmo N; Semmo M; Nia AM; Fuhr U; Er F
Eur J Clin Pharmacol; 2011 Apr; 67(4):333-346. PubMed ID: 21327910
[TBL] [Abstract][Full Text] [Related]
11. [Vasopressin antagonists in treatment of hyponatremia].
Olszewski W; Głuszek J
Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383
[TBL] [Abstract][Full Text] [Related]
12. [Vasopressin receptor antagonists: the vaptans].
Villabona C
Endocrinol Nutr; 2010 May; 57 Suppl 2():41-52. PubMed ID: 21130961
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin V2 receptor antagonists for the syndrome of inappropriate antidiuretic hormone secretion.
Tanemoto M
Int Urol Nephrol; 2024 Jan; 56(1):361-362. PubMed ID: 37219713
[No Abstract] [Full Text] [Related]
14. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
Wong F; Blei AT; Blendis LM; Thuluvath PJ
Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
[TBL] [Abstract][Full Text] [Related]
15. BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats.
Kazama I; Hatano R; Michimata M; Suzuki K; Arata T; Suzuki M; Miyama N; Sato A; Satomi S; Ejima Y; Sasaki S; Matsubara M
Kidney Int; 2005 May; 67(5):1855-67. PubMed ID: 15840033
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Ferguson JW; Therapondos G; Newby DE; Hayes PC
Clin Sci (Lond); 2003 Jul; 105(1):1-8. PubMed ID: 12639215
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of vasopressin receptor antagonists.
Ali F; Guglin M; Vaitkevicius P; Ghali JK
Drugs; 2007; 67(6):847-58. PubMed ID: 17428103
[TBL] [Abstract][Full Text] [Related]
18. The use of vasopressin receptor antagonists in hyponatremia.
Khanna A; Menon MC
Curr Opin Investig Drugs; 2010 Sep; 11(9):1007-14. PubMed ID: 20730695
[TBL] [Abstract][Full Text] [Related]
19. [Aquaretic drugs--a new therapeutic principle in treatment of hyponatremia?].
Hensen J; Buchfelder M; Gross P
Fortschr Med; 1997 Jun; 115(17):46-50. PubMed ID: 9312543
[TBL] [Abstract][Full Text] [Related]
20. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Saito T; Ishikawa S; Abe K; Kamoi K; Yamada K; Shimizu K; Saruta T; Yoshida S
J Clin Endocrinol Metab; 1997 Apr; 82(4):1054-7. PubMed ID: 9100572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
